Influence of Kidney Performance and Magnesium on Formation of (OH)2-vitamin D3

February 10, 2020 updated by: University Hospital, Basel, Switzerland

Influence of Kidney Performance and Magnesium on the Biomarkers of Vitamin D

Retrospective database analysis. The target values are the serum values of 25(OH)D, of 1,25(OH)2D, of magnesium and creatinine as well as age and sex of the patients. The laboratory values of the years 2017 and 2018 are included. There are no additional measurements on patients.

Study Overview

Status

Completed

Detailed Description

The laboratory values of the years 2017 and 2018 are included. All laboratory results to be evaluated originate from Medics Labor in Bern. We expect about 50'000 data sets. It is impossible for the study team to draw conclusions about the patients or the senders.

Study Type

Observational

Enrollment (Actual)

50000

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

no restriction

Description

Inclusion Criteria:

  • all data sets available

Exclusion Criteria:

  • a declaration from the patient that his laboratory values may not be included in an evaluation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
correlation of serum values of 1,25(OH)2 vitamin D with estimated glomerular filtration rate
Time Frame: 2017 - 2018
statistical evaluation of serum values
2017 - 2018
correlation of serum values of 1,25(OH)2 vitamin D with magnesium
Time Frame: 2017 - 2018
statistical evaluation of serum values
2017 - 2018

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2017

Primary Completion (Actual)

December 31, 2018

Study Completion (Actual)

May 28, 2019

Study Registration Dates

First Submitted

January 17, 2020

First Submitted That Met QC Criteria

January 22, 2020

First Posted (Actual)

January 23, 2020

Study Record Updates

Last Update Posted (Actual)

February 11, 2020

Last Update Submitted That Met QC Criteria

February 10, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hydroxylase Deficiency

Clinical Trials on serum value 1,25(OH)2 vitamin D

3
Subscribe